Taich Adam sold TXG

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001610717-26-000414

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 9, 2026

Published

Sep 11, 2026

Ingested by INSIDER

Nov 5, 02:17 UTC

Last re-read

Nov 5, 02:17 UTC

Extracted facts

Filer

Taich Adam

Role

Chief Financial Officer

Transaction

Open-market saleAs filed: “S”

Asset

10x Genomics, Inc.

Ticker

TXG

Shares

13.8K

Price per share

$65.26

Value

$897,550

Execution date (reported)

Sep 9, 2026

Owned after transaction

316.3K shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

2

Calculation

What this establishes

Taich Adam filed this Form 4 reporting a open-market sale of TXG on Sep 9, 2026. It became public on Sep 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Financial Officer

Taich Adamcik:0001971187

Issuer

10x Genomics, Inc.cik:0001770787

Revision history · 0

No field has changed since this record was first ingested.